Endometrial Ablation Market Size, Share, Trends, Industry Analysis Report: By Type (Devices and Procedures), Device Type, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034
- Published Date:May-2025
- Pages: 118
- Format: PDF
- Report ID: PM2155
- Base Year: 2024
- Historical Data: 2020-2023
Endometrial Ablation Market Overview
The endometrial ablation market size was valued at USD 1,250.93 million in 2024. The market is projected to grow from USD 1,311.60 million in 2025 to USD 2,052.22 million by 2034, exhibiting a CAGR of 5.1% during 2025–2034.
The endometrial ablation market refers to the segment of the medical industry focused on minimally invasive procedures designed to remove or destroy the lining of the uterus. This treatment is primarily used to address abnormal uterine bleeding in individuals who do not respond to medication and wish to avoid major surgery. As a less invasive alternative to hysterectomy, endometrial ablation has gained widespread adoption due to its effectiveness in reducing excessive menstrual bleeding and improving overall patient well-being. The market encompasses a range of devices and techniques, including thermal balloon ablation, radiofrequency ablation, and microwave energy-based procedures, each offering unique benefits for patients and healthcare providers.
To Understand More About this Research: Request a Free Sample Report
The increasing prevalence of abnormal uterine bleeding, coupled with the rising awareness of minimally invasive treatments, has significantly contributed to the endometrial ablation market growth. Additionally, advancements in medical devices engineering have led to the development of safer and more efficient procedures, further encouraging endometrial ablation adoption. The growing preference for outpatient treatments, which reduce hospital stays and associated costs, has also played a crucial role in market growth. Moreover, an aging female population and increasing healthcare expenditure in developed and developing regions are expected to support the continued expansion of the market in the coming years.
Endometrial Ablation Market Dynamics
Increasing Prevalence of Abnormal Uterine Bleeding (AUB)
The rising incidence of abnormal uterine bleeding (AUB) significantly contributes to the endometrial ablation market demand. AUB encompasses irregularities in menstrual cycles, including variations in frequency, regularity, duration, and volume of flow, affecting reproductive-aged women globally. The prevalence of AUB among reproductive-aged women internationally is estimated to be between 3% and 30%, with a higher incidence occurring around menarche and perimenopause. This substantial prevalence underscores the need for effective treatment options. Endometrial ablation offers a minimally invasive solution for managing AUB, particularly in cases unresponsive to medical therapy. As awareness of AUB increases and more individuals seek treatment, the demand for endometrial ablation procedures is expected to rise, thereby driving the endometrial ablation market development.
Advancements in Endometrial Ablation Techniques
Technological innovations in endometrial ablation techniques have played a pivotal role in the endometrial ablation market expansion. Second-generation endometrial ablation devices, such as thermal balloon ablation, bipolar radiofrequency ablation, and microwave ablation, have been developed to improve patient outcomes and procedural efficiency. A network meta-analysis published in the British Medical Journal in 2025 compared these techniques and found that bipolar radiofrequency and microwave ablation were associated with higher rates of amenorrhea compared to thermal balloon ablation. These advancements have led to safer, more effective, and less invasive treatment options, making endometrial ablation a more attractive choice for both patients and healthcare providers. Consequently, the continuous development and adoption of these advanced techniques are propelling the market growth.
Shift Towards Outpatient and Minimally Invasive Procedures
The healthcare industry's shift towards outpatient and minimally invasive procedures has significantly impacted the endometrial ablation market trends. Minimally invasive surgeries such as endometrial ablation offer reduced recovery times, lower complication rates, and decreased healthcare costs compared to more invasive surgical options. This trend aligns with the broader healthcare objective of enhancing patient experience while optimizing resource utilization. The demand for procedures such as endometrial ablation continues to grow as healthcare systems and patients increasingly prefer treatments that allow for rapid recovery and minimal hospital stays.
Endometrial Ablation Market Segment Insights
Endometrial Ablation Market Assessment By Type
The endometrial ablation market, by type, is bifurcated into devices and procedures. The devices segment accounted for a major endometrial ablation market share in 2024, driven by the effectiveness and efficiency of the various ablation devices such as radiofrequency and thermal balloon systems. These devices are widely adopted for their proven results in reducing abnormal uterine bleeding with minimal patient recovery time, making them a preferred choice in clinical settings. Additionally, the widespread availability and established use of these devices in the medical community have contributed to their dominance. The increasing number of regulatory approvals for advanced devices is further accelerating the expansion of the segment.
The procedures segment is witnessing significant growth, driven by technological advancements that enhance precision and effectiveness. Furthermore, the procedure's adaptability to various clinical settings and compatibility with existing infrastructure contribute to its adoption. As healthcare systems increasingly focus on innovative treatments, the procedure's unique benefits are driving its expansion within the endometrial ablation market.
Endometrial Ablation Market Evaluation By Device Type
The endometrial ablation market, by device type, is segmented into cryoablation, radiofrequency, hydrothermal, thermal balloon, microwave energy, and hysteroscopy. Among these, the radiofrequency segment dominated the endometrial ablation market revenue share in 2024. This dominance is attributed to the device's convenience, rapid treatment process, high effectiveness, and cost-efficiency compared to other ablation devices. Additionally, the widespread availability and established use of radiofrequency devices in the medical community have contributed to their prominence. The increasing number of regulatory approvals for advanced devices is further accelerating the expansion of the segment. For instance, in February 2023, Hologic Inc. secured approval for its NovaSure V5 global endometrial ablation device in Canada and Europe. This next-generation device incorporates innovative features designed to enhance patient outcomes and procedural efficiency, contributing to its adoption across these regions.
The thermal balloon segment is witnessing the fastest growth rate, driven by the procedure's simplicity, safety, and effectiveness in permanently treating dysfunctional uterine bleeding in selected cases. Thermal balloon ablation involves the insertion of a balloon filled with heated fluid into the uterus to destroy the endometrial lining, offering a minimally invasive alternative to more extensive surgical procedures. The availability of various thermal balloon devices, such as Cavaterm, Thermachoice, Thermablate, and Menotreat, provides healthcare providers with multiple options to tailor treatment to individual patient needs. As awareness of these benefits increases among both patients and healthcare professionals, the adoption of thermal balloon ablation is expected to rise during the forecast period.
Endometrial Ablation Market Outlook By End Use
The endometrial ablation market, by end use, is segmented into hospitals, clinics, and ambulatory surgery centers. The hospitals segment dominated the market share in 2024. This prominence is attributed to the comprehensive care and advanced medical technologies available in hospital settings, which are well-equipped to handle complex gynecological cases and provide post-operative care essential for procedures such as endometrial ablation. Additionally, hospitals offer proper care and reimbursements and possess advanced treatment devices, contributing to the expansion of the segment. Furthermore, the ease of managing any problems that may develop during surgical procedures and the availability of a wide range of treatment options in hospitals leads to a substantially higher inflow of patients for gynecological treatments compared to other healthcare settings.
The ambulatory surgery centers segment is experiencing the fastest growth rate, driven by the increasing preference for minimally invasive procedures that allow for shorter recovery times and reduced healthcare costs. Ambulatory surgery centers offer a cost-effective and convenient alternative to traditional hospital settings, making them an attractive option for both patients and healthcare providers. The focus on personalized treatments, minimal waiting times, and a well-suited environment further enhance their appeal. As the number of ambulatory surgery centers continues to rise and their capabilities expand, their role in providing endometrial ablation procedures is becoming more significant, thereby driving the growth of the segment within the endometrial ablation market.
Endometrial Ablation Market by Regional Outlook
By region, the report offers endometrial ablation market insights into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America dominated the endometrial ablation market share in 2024. This dominance is attributed to a high prevalence of gynecological conditions, advanced healthcare infrastructure, and widespread adoption of innovative medical technologies. The presence of key market players and increasing preference for minimally invasive surgical procedures further boost the market in the region. Additionally, supportive government policies and favorable reimbursement frameworks enhance patient access to endometrial ablation treatments, contributing to the region's dominant position in the global market.
The Asia Pacific endometrial ablation market is witnessing the fastest growth rate. Factors driving this rapid expansion include a growing prevalence of gynecological disorders, improving healthcare infrastructure, and increasing awareness about women's health issues. Countries such as China, India, and Japan are at the forefront of this growth, with rising disposable incomes and government initiatives aimed at modernizing medical facilities. The expanding middle-class population and enhanced access to healthcare services further fuel the demand for minimally invasive procedures such as endometrial ablation, positioning Asia Pacific as a significant contributor to the market's future development.
Endometrial Ablation Market – Key Players and Competitive Analysis Report
The endometrial ablation market features several prominent companies actively offering relevant products and services. A few notable players include AEGEA Medical, Inc.; AngioDynamics, Inc.; Boston Scientific Corporation; Channel MedSystems; CooperSurgical, Inc.; Hologic, Inc.; Idoman Teoranta; Johnson & Johnson Services, Inc.; Karl Storz; Medtronic plc; Minerva Surgical, Inc.; Olympus Corporation; Omnitech Systems, Inc.; Richard Wolf GmbH; and Veldana Medical SA.
The competitive landscape of the endometrial ablation market is characterized by continuous innovation, strategic collaborations, and a focus on expanding product portfolios. Companies are investing in research and development to introduce advanced devices with enhanced safety and efficiency. Partnerships and acquisitions are also being pursued to expand geographical reach and strengthen market positions.
Hologic, Inc., headquartered in Massachusetts, US, is a global medical technology company specializing in women's health. The company develops, manufactures, and distributes diagnostic and surgical products, including the NovaSure endometrial ablation system, which utilizes radiofrequency energy to treat abnormal uterine bleeding. Hologic's commitment to advancing women's health through innovative solutions has contributed to its relevance in the endometrial ablation market.
Boston Scientific Corporation, based in Massachusetts, United States, is a multinational manufacturer of medical devices. The company's Genesys HTA system combines hydrothermal energy with an expandable mesh device to ablate the endometrial lining, offering a minimally invasive treatment for menorrhagia. Boston Scientific's focus on technological innovation and expanding its product offerings underscores its significant role in the endometrial ablation market.
List of Key Companies in Endometrial Ablation Market
- AEGEA Medical, Inc.
- AngioDynamics, Inc.
- Boston Scientific Corporation
- Channel MedSystems
- CooperSurgical, Inc.
- Hologic, Inc.
- Idoman Teoranta
- Johnson & Johnson Services, Inc.
- Karl Storz
- Medtronic plc
- Minerva Surgical, Inc.
- Olympus Corporation
- Omnitech Systems, Inc.
- Richard Wolf GmbH
- Veldana Medical SA
Endometrial Ablation Industry Developments
- November 2024: Olympus Corporation of the Americas presented its extensive range of gynecological solutions at the AAGL World Congress. The showcase featured hysteroscopy systems equipped with Plasma Hysteroscopic Resection and Vaporization Electrodes, along with the VERSAPOINT II Bipolar Electrosurgery System, designed for procedures such as endometrial ablation.
- October 2024: Minerva Surgical partnered with Blackmaple Group to provide WHAAPA physician members with access to minimally invasive gynecologic technologies. The agreement includes the Minerva ES Ablation System and the Medical Endoscopy Image Processing System, aimed at diagnosing and treating abnormal uterine bleeding (AUB).
Endometrial Ablation Market Segmentation
By Type Outlook (Revenue-USD Million, 2020–2034)
- Devices
- Procedures
By Device Type Outlook (Revenue-USD Million, 2020–2034)
- Cryoablation
- Radiofrequency
- Hydrothermal
- Thermal Balloon
- Microwave energy
- Hysteroscopy
By End Use Outlook (Revenue-USD Million, 2020–2034)
- Hospitals
- Clinics
- Ambulatory Surgery Centers
By Regional Outlook (Revenue-USD Million, 2020–2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- Suth Korea
- Indnesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- Suth Africa
- Rest of Middle East & Africa
- Latin America
- Mexic
- Brazil
- Argentina
- Rest of Latin America
Endometrial Ablation Market Report Scope
|
Report Attributes |
Details |
|
Market Size in 2024 |
USD 1,250.93 million |
|
Market Value in 2025 |
USD 1,311.60 million |
|
Revenue Forecast by 2034 |
USD 2,052.22 million |
|
CAGR |
5.1% from 2025 to 2034 |
|
Base Year |
2024 |
|
Historical Data |
2020–2023 |
|
Forecast Period |
2025–2034 |
|
Quantitative Units |
Revenue in USD million and CAGR from 2025 to 2034 |
|
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Industry Insights |
|
Segments Covered |
|
|
Regional Scope |
|
|
Competitive Landscape |
|
|
Report Format |
|
|
Customization |
Report customization as per your requirements with respect to countries, regions, and segmentation. |
How is the report valuable for an organization?
Workflow/Innovation Strategy: The endometrial ablation market has been segmented into detailed segments of type, device type, and end use. Moreover, the study provides the reader with a detailed understanding of the different segments at both the global and regional levels.
Growth/Marketing Strategy: The endometrial ablation market growth and marketing strategies focus on expanding product offerings, enhancing technological advancements, and increasing geographic reach. Key players are investing heavily in research and development to introduce more effective and minimally invasive treatment options, such as advanced radiofrequency and cryoablation systems. Strategic partnerships, and mergers and acquisitions are also being pursued to strengthen market presence and broaden product portfolios. Additionally, companies are focusing on increasing awareness and improving patient access through educational campaigns, collaborations with healthcare providers, and expanding distribution networks in emerging markets. These strategies are designed to capitalize on the rising demand for minimally invasive gynecological treatments globally.
FAQ's
The endometrial ablation market size was valued at USD 1,250.93 million in 2024 and is projected to grow to USD 2,052.22 million by 2034.
The market is projected to register a CAGR of 5.1% during the forecast period
North America held the largest share of the market in 2024.
A few key players in the market include AEGEA Medical, Inc.; AngioDynamics, Inc.; Boston Scientific Corporation; Channel MedSystems; CooperSurgical, Inc.; Hologic, Inc.; Idoman Teoranta; Johnson & Johnson Services, Inc.; Karl Storz; Medtronic plc; Minerva Surgical, Inc.; Olympus Corporation; Omnitech Systems, Inc.; Richard Wolf GmbH; and Veldana Medical SA.
The hospitals segment accounted for the largest share of the market in 2024.
Following are a few of the endometrial ablation market trends: ? Minimally Invasive Procedures: There's a growing preference for minimally invasive procedures due to shorter recovery times, reduced complication risks, and lower healthcare costs. ? Technological Advancements: Continuous innovation in ablation technologies, such as radiofrequency, cryoablation, and thermal balloon, is enhancing treatment effectiveness and patient outcomes. ? Rising Adoption of Outpatient Care: Increasing use of ambulatory surgery centers (ASCs) and outpatient settings for endometrial ablation procedures, driven by convenience and cost-effectiveness.
Endometrial ablation is a medical procedure used to treat abnormal uterine bleeding (AUB) by destroying the endometrial lining of the uterus. This procedure is typically recommended for women who experience heavy or prolonged menstrual periods that don't respond well to other treatments. The goal of endometrial ablation is to reduce or stop menstrual bleeding entirely, thereby improving the patient's quality of life. Various techniques can be used for endometrial ablation, including radiofrequency, cryoablation, thermal balloon, microwave energy, and hydrothermal methods. The procedure is generally minimally invasive, performed in outpatient settings, and can be a less risky and more effective alternative to a hysterectomy (removal of the uterus).
© 2025 Polaris Market Research and Consulting. All rights reserved
